vTv Therapeutics appoints Tuch as Chief Financial Officer

vTv Therapeutics (VTVT) announced the appointment of Steven Tuch as Chief Financial Officer, effective immediately. Prior to joining vTv, he served as Head of Corporate Development at Rallybio Corporation (RLYB), leading the Company through its $92.7 million IPO in July 2021. "Steven’s success in capital raising and business development, combined with his range of work in the life science and healthcare industry, makes us confident that he is an excellent fit for the position and our needs," said Paul Sekhri, President and Chief Executive Officer of vTv Therapeutics. "We anticipate that he will play a pivotal role as we actively prepare to initiate, then execute on, our Phase 3 trials for our lead drug candidate, TTP399."